AI Weekly Malaysia

BBC Future reports on Vermont's Green Mountain Power programme, which leases two home batteries to participants for $55 per month over 10 years; one participant chose it over a $12,000 gas generator and says she has not lost power since the 2024 installation. More than 5,500 homes now form a virtual power plant that GMP says is Vermont's largest power source. The US has over 40GW of VPP capacity today, and a 2025 Department of Energy report estimates 160GW could be unlocked by 2030, about 20% of expected peak demand.

Why: There is no Malaysia or Southeast Asia policy, pricing, or utility detail here, so for most local AI/ML and SaaS builders this is not an immediate action item. It matters if you are building distributed energy, IoT, or utility orchestration software: the concrete model is a $55/month battery lease aggregated across 5,500+ homes, replacing a $12,000 generator, which is a different unit economic and software problem from standard SaaS.

The supplied page content contains only Ars Technica's consent-management and cookie-notice text; the actual article body about Google watermarking AI-designed proteins is not present. The only substantive information available is the headline itself and the publication timestamp of 2026-09-30. No method, paper, tool, model name, or result is described in the text.

Why: There is nothing here a builder can act on: no technique, no released tool, no API, no measurement. Anyone wanting to know whether AI-generated protein sequences can be marked and later detected will have to read the original article, because this excerpt does not say how the watermarking works or whether it is robust. Do not cite this as evidence of a usable watermarking capability yet.

The fetched page contains no article body: the only text is Ars Technica/Conde Nast consent and cookie-preference boilerplate (opt-out language for US states, essential/performance/audience-measurement cookie toggles). The headline claims a local network of implants that communicates through body tissue, but no study details, device counts, data rates, frequencies, researchers, institutions, or publication venue appear in the supplied text. Nothing in this item can be verified or summarized beyond its title.

Why: Nothing actionable here — there is no technical detail, date, number, or named source to act on. If you want this story in the segment, re-fetch the article body or find the underlying paper first; do not present the headline as a finding, because a consent-wall capture is not evidence the study exists as described. For a Malaysian builder audience this has no near-term product, policy, cloud, payments, or startup implication either way.